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Objectives Acetyl-L-Carnitine (ALC) has been described as playing a neuroprotective effect 
against a variety of substances. However, the molecular mechanisms underlying its action, 
particularly regarding the induction of changes in neurotransmitter system, are still not fully 
understood. Using both a cell line and an animal model of exposure to methamphetamine 
(METH), we aim to contribute to clarify the mechanism by which the administration of ALC 
alters neurotransmitter release. 
 
Methods Rat pheochromocytoma PC12 cells were treated with increasing doses of ALC 
(0.01 to 1.0 mM) alone or in combination with METH 1.0 or 100 µM for 24h or 72h. When ALC 
and METH were combined, pre-treatment with ALC preceded METH exposure in 30 min. 
Dopamine (DA) content was determined by high performance liquid chromatography. In 
vivo assays using C57BL/6J mice were performed to assess DA striatal binding. Mice were 
divided into 4 groups, according to different treatments: group 1 (control), group 2 (ALC, 100 
mg/kg), group 3 (METH, 10 mg/kg) and group 4 (ALC+METH). 123I-IBZM was injected and 
images were acquired in a SPECT/CT scanner (NanoSPECT/CT, Mediso, Hungary) 70 
minutes after injection. Regions of interest were drawn over the left and right striatum as 
well as in the cerebellum in order to determine the striatal binding ratio. 
 
Results Increased intracellular levels of DA were observed in PC12 cells at 24h and 72h after 
the administration of ALC. When cells were treated with METH 100 µM, intracellular levels 
of DA were clearly decreased. ALC was effective in preventing the METH-induced decrease 
of DA concentration (p<0.0001). In mice, the challenge with a single dose of 10 mg/kg of 
METH decreased striatal D2R binding ratios relative to the control group between 20% and 
30%. Interestingly, over time, ALC was able to reverse the decrease on the radiotracer 
binding induced by METH. 
 
Conclusions The present study demonstrates a possible effect of ALC over METH-induced 
DA release. 
